Sphera Funds Management Ltd. Immunic, Inc. Transaction History

Sphera Funds Management Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.13 - $12.25 $1.83 Million - $7.14 Million	-583,206 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$9.54 - $14.26 $795,597 - $1.19 Million	-83,396 Reduced 12.51%	583,206 $6.59 Million
Q4 2021 Feb 14, 2022	BUY	$7.34 - $10.25 $2.03 Million - $2.84 Million	276,790 Added 71.01%	666,602 $6.38 Million
Q3 2021 Nov 15, 2021	BUY	$8.05 - $13.29 $3.14 Million - $5.18 Million	389,812 New	389,812 $3.45 Million
Q3 2020 Nov 12, 2020	SELL	$11.74 - $22.0 $1.17 Million - $2.2 Million	-100,000 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$5.67 - $15.86 $567,000 - $1.59 Million	100,000 New	100,000 $1.21 Million

56.1M

4.7K

311K

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $50.4M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.